In order to obtain this action we must pay 150,24$ right now, Alnylam Pharmaceuticals Inc, with address at 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE, CAMBRIDGE, Massachusetts, 2142, United States, is a publicly traded company and its visible heads at the moment are Akshay K. Vaishnaw (President-Research & Development), Al Boyle (Chief Technical Operations & Quality Officer), James P. Bilotta (Chief Information Officer & SVP), Jeffrey Poulton (Chief Financial & Accounting Officer), John M. Maraganore (Chief Executive Officer & Director), Kevin Fitzgerald (Chief Scientific Officer & Senior Vice President), Pushkal Garg (Chief Medical Officer), Yvonne L. Greenstreet (President & Chief Operating Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.

Yesterday this stock ended the day with a value of desconocido$.

The current range on the same day is from 147,80$ - 150,78$, with a percentage difference of 149,29$ quite wide that helps to be able to do day trading.

Their latest annual data shows an income of desconocido.

The opening price that appears as last recorded is desconocido.

If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.

Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.